Skip to main content
. Author manuscript; available in PMC: 2010 Oct 12.
Published in final edited form as: Eur J Pharmacol. 2009 Aug 19;620(1-3):138–144. doi: 10.1016/j.ejphar.2009.08.022

Fig. 1.

Fig. 1

Effects of CDDO-Im on body weight gain of (A) wild-type mice and (B) Nrf2-disrupted mice. Mice fed a control diet (Con) or a high-fat diet (HF) for 95 days were dosed with 30 μmol/kg body weight CDDO-Im or vehicle by gavage 3 times per week throughout the feeding period with both diets. Body weights were monitored before each treatment, 3 times per week. Data represent mean ± S.E.M., n = 8–15 per group.